UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

Journal of clinical oncology, 2011-06, Vol.29 (18), p.2528-2533

2011

Volltextzugriff (PDF)

Inhaled corticosteroids may have a protective effect against coronavirus infection

Allergologia et immunopathologia, 2021-01, Vol.49 (1), p.113-117

2021

Volltextzugriff (PDF)

Role of Surgery in Patients with Recurrent, Metastatic, or Unresectable Locally Advanced Gastrointestinal Stromal Tumors Sensitive to Imatinib: A Retrospective Analysis of the Spanish Group for Research on Sarcoma (GEIS)

Annals of surgical oncology, 2015-09, Vol.22 (9), p.2948-2957

2015

Volltextzugriff (PDF)

18F-FDG PET/CT of Lung Adenocarcinoma With Ovarian Metastases

Clinical nuclear medicine, 2019-05, Vol.44 (5), p.397-398

2019

Volltextzugriff (PDF)

Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: results of a prospective randomized phase II study

Investigational new drugs, 2006-05, Vol.24 (3), p.241-248

2006

Volltextzugriff (PDF)

Abstract 5416: RNA-seq and proteomics to identify response to immunotherapy in advanced melanoma: a Spanish Melanoma Group Study

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5416-5416

2022

Volltextzugriff (PDF)

An ethical Response in the Care of Nursing Homes in the COVID-19 Pandemic

Cuadernos de bioética, 2020-05, Vol.31 (102), p.223

Equipo COVID Residencias, Área de Salud Valladolid Oeste

2020

Volltextzugriff (PDF)

Pegylated Liposomal Doxorubicin and Gemcitabine in a Fixed Dose Rate Infusion for the Treatment of Patients With Poor Prognosis of Recurrent Ovarian Cancer: A Phase Ib Study

International journal of gynecological cancer, 2011-04, Vol.21 (3), p.478-485

2011

Volltextzugriff (PDF)

Abstract PO-005: Spatio-temporal geographical molecular mapping of primary papillary thyroid carcinomas and paired distant metastases: Clinical relevance for monitoring and targeting tumor heterogeneity

Cancer research (Chicago, Ill.), 2020-11, Vol.80 (21_Supplement), p.PO-005-PO-005

2020

Volltextzugriff (PDF)

Phase II trial of ifosfamide in combination with sorafenib in patients with advanced soft tissue sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.10523-10523

2013

Volltextzugriff (PDF)

Phase I clinical trial of fixed–dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation

Cancer, 2004-11, Vol.101 (10), p.2261-2269

2004

Volltextzugriff (PDF)

Analysis of the p38MAPK pathway in the prognosis of patients with surgically resected stage I-II NSCLC

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e18513-e18513

2013

Volltextzugriff (PDF)

Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: A Phase II trial by the Spanish Group for Research on Sarcomas (GEIS)

Cancer, 2004-04, Vol.100 (7), p.1498-1506

2004

Volltextzugriff (PDF)

Phase II study of neoadjuvant high-dose ifosfamide with concurrent radiotherapy followed by surgical resection in high-risk soft tissue sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10052-10052

2012

Volltextzugriff (PDF)

Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de Asturias

Clinical & translational oncology, 2010-08, Vol.12 (8), p.562-567

2010

Volltextzugriff (PDF)

Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: a phase II study

Investigational new drugs, 2011-12, Vol.29 (6), p.1459-1464

2011

Volltextzugriff (PDF)

Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study

Clinical sarcoma research, 2016-06, Vol.6 (1), p.10-10, Article 10

2016

Volltextzugriff (PDF)

Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study

Investigational new drugs, 2008-02, Vol.26 (1), p.67-74

2008

Volltextzugriff (PDF)

Dolor torácico y disnea en una paciente con nódulos pulmonares bilaterales

Medicina paliativa, 2018-01, Vol.25 (1), p.57-58

2018

Volltextzugriff (PDF)

P2-254: Pulmonary toxicity in patients treated with a combination of gemcitabine (G) associated to docetaxel (D) or vinorelbine (V) for advanced non-small cell lung cancer (NSCLC): outcome data on a randomized phase II study

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S673-S674

2007

Volltextzugriff (PDF)

P2-318: Activity of intravenous Topotecan in patients with advanced non-small cell lung cancer pre-treatred with platinum and taxanes: Results of the first analysis

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S699-S700

2007

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(84)
Bücher
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(31)
Humans
(25)
Oncology
(23)
Female
(22)
Male
(22)
Middle Aged
(20)
Adult
(19)
Aged
(19)
Treatment Outcome
(13)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Chemotherapy
(9)
Deoxycytidine - Administration & Dosage
(9)
Deoxycytidine - Analogs & Derivatives
(9)
Cancer Therapies
(8)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(8)
Lung Neoplasms - Drug Therapy
(8)
Toxicity
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma

Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma

Inhaled corticosteroids may have a protective effect against coronavirus infection

Efficacy of Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft Tissue Sarcoma: An Open-Label Randomized Phase II Study of the Spanish Group for Research on Sarcomas

Role of Surgery in Patients with Recurrent, Metastatic, or Unresectable Locally Advanced Gastrointestinal Stromal Tumors Sensitive to Imatinib: A Retrospective Analysis of the Spanish Group for Research on Sarcoma (GEIS)

18F-FDG PET/CT of Lung Adenocarcinoma With Ovarian Metastases

Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: results of a prospective randomized phase II study

Abstract 5416: RNA-seq and proteomics to identify response to immunotherapy in advanced melanoma: a Spanish Melanoma Group Study

An ethical Response in the Care of Nursing Homes in the COVID-19 Pandemic

Pegylated Liposomal Doxorubicin and Gemcitabine in a Fixed Dose Rate Infusion for the Treatment of Patients With Poor Prognosis of Recurrent Ovarian Cancer: A Phase Ib Study

Abstract PO-005: Spatio-temporal geographical molecular mapping of primary papillary thyroid carcinomas and paired distant metastases: Clinical relevance for monitoring and targeting tumor heterogeneity

Phase II trial of ifosfamide in combination with sorafenib in patients with advanced soft tissue sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study

Phase I clinical trial of fixed–dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation

Analysis of the p38MAPK pathway in the prognosis of patients with surgically resected stage I-II NSCLC

Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: A Phase II trial by the Spanish Group for Research on Sarcomas (GEIS)

Phase II study of neoadjuvant high-dose ifosfamide with concurrent radiotherapy followed by surgical resection in high-risk soft tissue sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study

Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de Asturias

Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: a phase II study

Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study

Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study

Efficacy of Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft Tissue Sarcoma : AnOpen-Label Randomized Phase II Study of the Spanish Group for Research on Sarcomas

Dolor torácico y disnea en una paciente con nódulos pulmonares bilaterales

P2-254: Pulmonary toxicity in patients treated with a combination of gemcitabine (G) associated to docetaxel (D) or vinorelbine (V) for advanced non-small cell lung cancer (NSCLC): outcome data on a randomized phase II study

P2-318: Activity of intravenous Topotecan in patients with advanced non-small cell lung cancer pre-treatred with platinum and taxanes: Results of the first analysis

Suchergebnisse filtern